Alnylam Pharmaceuticals
ALNY
#868
Rank
C$40.85 B
Marketcap
C$305.34
Share price
-0.17%
Change (1 day)
-48.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company